ACXP - CIK 0001736243
Acurx Pharmaceuticals, Inc. trades as ACXP. This page tracks Acurx Pharmaceuticals, Inc. through 232 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| 424B3 | - | 2026-05-12 |
| 424B3 | - | 2026-05-12 |
| EFFECT | - | 2026-05-11 |
| EFFECT | - | 2026-05-11 |
| Quarterly report | 10-Q | 2026-05-11 |
| IPO registration | S-1 | 2026-05-04 |
| IPO registration | S-1 | 2026-05-04 |
| D | - | 2026-04-29 |
The largest companies sharing Acurx Pharmaceuticals, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Acurx Pharmaceuticals, Inc. reported a net loss of $7.97M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.